Mirae Asset Global Investments
TDOC icon

Mirae Asset Global Investments’s Teladoc Health TDOC Stock Holding History

Mirae Asset Global Investments’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1K Buy
+10,271
New +$68.3K ﹤0.01% 1263
2024
Q3 		– Sell
-1,347
Closed -$13.7K – 1593
2024
Q2 		$13.7K Sell
1,347
-208,342
-99% -$2.54M ﹤0.01% 1433
2024
Q1 		$5.08M Buy
209,689
+60,780
+41% +$1.1M 0.01% 891
2023
Q4 		$3.21M Sell
148,909
-28,648
-16% -$529K 0.01% 1058
2023
Q3 		$3.3M Sell
177,557
-14,165
-7% -$331K 0.01% 984
2023
Q2 		$4.85M Sell
191,722
-26,853
-12% -$676K 0.01% 891
2023
Q1 		$5.66M Sell
218,575
-3,417
-2% -$91.4K 0.01% 831
2022
Q4 		$5.25M Buy
221,992
+83,594
+60% +$2.25M 0.01% 807
2022
Q3 		$3.51M Sell
138,398
-7,073
-5% -$248K 0.01% 923
2022
Q2 		$4.83M Buy
145,471
+23,705
+19% +$1.01M 0.01% 850
2022
Q1 		$8.78M Sell
121,766
-12,571
-9% -$906K 0.02% 709
2021
Q4 		$12.4M Sell
134,337
-41,930
-24% -$5.01M 0.03% 615
2021
Q3 		$22.4M Sell
176,267
-20,224
-10% -$2.94M 0.06% 386
2021
Q2 		$32.7M Buy
196,491
+43,947
+29% +$7.12M 0.09% 277
2021
Q1 		$27.7M Sell
152,544
-81,996
-35% -$19M 0.1% 271
2020
Q4 		$46.9M Buy
234,540
+100,800
+75% +$20.5M 0.17% 151
2020
Q3 		$29.1M Sell
133,740
-127,343
-49% -$27M 0.14% 163
2020
Q2 		$49.8M Buy
261,083
+205,316
+368% +$36M 0.3% 61
2020
Q1 		$8.64M Sell
55,767
-21,321
-28% -$2.48M 0.07% 308
2019
Q4 		$6.45M Buy
77,088
+32,088
+71% +$2.44M 0.04% 448
2019
Q3 		$3.05M Hold
45,000
– – 0.02% 599
2019
Q2 		$2.99M Hold
45,000
– – 0.02% 598
2019
Q1 		$2.5M Buy
+45,000
New +$2.75M 0.02% 586
2018
Q4 		– Sell
-47,400
Closed -$4.09M – 1349
2018
Q3 		$4.09M Buy
47,400
+15,300
+48% +$1.09M 0.03% 464
2018
Q2 		$1.86M Sell
32,100
-13,500
-30% -$659K 0.03% 386
2018
Q1 		$1.84M Buy
+45,600
New +$1.72M 0.02% 389

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Mirae Asset Global Investments's TDOC Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in Teladoc Health (TDOC) in Q2 2026: 10,271 shares worth $87.1K. The stake represents ﹤0.01% of the portfolio and ranks #1263 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in TDOC as recently as Q2 2024.

Mirae Asset Global Investments first reported a position in TDOC in Q1 2018 and has held it in 26 quarters since. The position peaked at $49.8M in Q2 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Mirae Asset Global Investments held 10,271 shares of Teladoc Health worth $87.1K as of Q2 2026.
  • Teladoc Health was a new Mirae Asset Global Investments position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1263 holding.
  • Mirae Asset Global Investments first reported a position in Teladoc Health in Q1 2018 and has held it in 26 quarters since.
  • Mirae Asset Global Investments's Teladoc Health position peaked at $49.8M in Q2 2020.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.